Increasing cases of respiratory emergencies and chronic obstructive pulmonary disease (COPD) are the major factors augmenting the market growth. According to the Institute for Health Metrics and Evaluation, in 2017, 299 million people suffered from moderate to severe COPD, globally. Moreover, technological innovations in respiratory care devices contribute to the market expansion. The advent of patient-friendly, cost-effective, and portable devices further encourage their usage. Developments, in terms of efficiency, design, and safety, resulted in significant benefits, such as improved weaning, better gas exchange, better oxygenation, and least damage to the lungs.  Increasing target population base, requiring long-term treatment for chronic respiratory conditions, is expected to drive the demand. As per the report published by the United Nations, in 2017, the global geriatric population was around 962 million, and it is anticipated to reach over 2.1 billion by 2050. Improving healthcare infrastructure in emerging economies, along with rising awareness about the available treatments for chronic respiratory diseases, led to the rapid adoption of mechanical ventilators in these countries, boosting the overall market growth. Increasing government support, awareness level, disposable income, and private funding for prevention and efficient treatment of respiratory diseases are expected to drive the market over the forecast period. Increasing need for emergency treatment for prolonged illnesses and protracted treatment associated with lung diseases in children and adults are further expected to drive the market.

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. MARKET SEGMENTATION 

6. COMPANY PROFILES AND COMPETITIVE LANDSCAPE

7. MARKET OPPORTUNITIES AND FUTURE TRENDS